
Moderna says FDA has been constructive, but delays flu/COVID shot
Bengaluru: Moderna on Thursday pushed back the time frame for likely approval of a combination vaccine meant to protect against both COVID-19 and influenza, but said exchanges with U.S. drug regulators have remained constructive under Health Secretary and …